Kyowa Kirin Worldwide
JAPANopen
- Kyowa Kirin Co., Ltd. ( 日本語 )
- Kyowa Medical Promotion Co., Ltd.
- Kyowa Media Service Co., Ltd.
- Kyowa Iryo Kaihatsu Co., Ltd.
- FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. ( 日本語 / English )
- Kyowa Kirin plus Co., Ltd. ( 日本語 )
- Kyowa Kirin Frontier Co., Ltd. ( 日本語 )
NORTH AMERICAopen
- Kyowa Kirin USA Holdings, Inc. ( English )
- BioWa, Inc. ( English )
- Kyowa Kirin Pharmaceutical Development, Inc. ( English )
- Kyowa Kirin Pharmaceutical Research, Inc. ( English )
- Kyowa Kirin, Inc. ( English )
ASIAopen
- Kyowa Kirin Asia Pacific Pte. Ltd. ( English )
- Kyowa Hakko Kirin China Pharmaceutical Co., Ltd. ( 中文 )
- Kyowa Kirin Korea Co., Ltd. ( 한국어 )
- Kyowa Kirin Taiwan Co., Ltd. ( 中文 )
- Kyowa Kirin Hong Kong Co., Limited ( 中文 / English )
- Kyowa Kirin (Thailand) Co., Ltd. ( ภาษาไทย )
EUROPEopen
- Kyowa Kirin International plc ( English )
- Kyowa Kirin Ltd. ( English )
- Kyowa Kirin Pharma SAS ( français )
- Kyowa Kirin Farmaceutica, S.L.U. ( Español )
- Kyowa Kirin GmbH ( Deutsch )
- Kyowa Kirin Pharma B.V. - Netherlands ( Nederlands )
- Kyowa Kirin Pharma B.V. - Belgium & Luxembourg ( English )
- Kyowa Kirin S.r.l. - Italia ( Italiano )
- Kyowa Kirin AB - Sweden ( Svenska )
- Kyowa Kirin AB - Norway ( English )
- Kyowa Kirin AB - Finland ( English )
- Kyowa Kirin AB - Denmark ( English )

Notice

July 13, 2020: White Paper on the Unrecognized Burden of XLH in Adults in Europe
April 30, 2020: Kyowa Kirin’s Response to the COVID-19 Pandemic
April 8, 2020: Kyowa Kirin publishes "Cutaneous T-cell lymphoma (CTCL) Patient Experiences Report"
March 26, 2020: Kyowa Kirin Statement- Responding COVID-19 Situation